WS #13309

From 500 msgs · 9 key-dev

AstraZeneca is in talks to acquire Bristol Myers Squibb, sending AZN shares down 7% and likely boosting BMY, with implications for the pharma sector.

Pharma M&A: AstraZeneca-Bristol Myers talks

AstraZeneca is in talks to acquire Bristol Myers Squibb, sending AZN shares down 7% and likely boosting BMY, with implications for the pharma sector.

Full world state #13309 →